This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Source-linked HOXB9 Western blot protocol options, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-HOXB9 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, source-linked protocol options, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~28.1 kDa | |
| Gel | 12–15% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated + Ubl conjugation | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB Hallmark membership | |
| Isoform | 1 isoform(s) |
The M05689 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | MCF7 cell lysate (catalog M05689) |
| Gel % | 12–15% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Short semi-dry transfer; verify retention (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M05689; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
HOXB9 is predicted at 28.1 kDa; phosphorylation and Ubl conjugation could affect migration, but no empirical band size or visible shift is established.
| Band near 28.1 kDa | Consistent with the predicted size of HOXB9; confirm its identity with controls |
| Closely spaced bands near 28.1 kDa | Phosphorylation at Thr133 could contribute, but a visible shift is not established |
| Band above 28.1 kDa | Ubl conjugation is annotated, but the band’s identity requires confirmation |
| Weak band in whole-cell lysate | Nuclear HOXB9 may be recovered more effectively in a nuclear fraction |
| Predicted molecular mass | Places unmodified HOXB9 near 28.1 kDa |
| Phosphothreonine at Thr133 | May affect migration, but no resolvable size change is established |
| Ubl conjugation annotation | Could produce a higher apparent mass if HOXB9 is conjugated; no band size is established |
| Nuclear localization | Affects sample recovery rather than intrinsic molecular mass |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | Nuclear HOXB9 may be poorly recovered | Check a nuclear fraction and verify fraction recovery |
| Band higher than expected | Possible Ubl conjugation or an unidentified band | Confirm HOXB9 identity with a second antibody or HOXB9 depletion |
| Band lower than expected | A fragment or an unidentified band; no cleavage feature is listed | Check sample integrity and confirm identity by HOXB9 depletion |
| Multiple bands | Modified HOXB9 species or unrelated antibody binding | Compare bands after HOXB9 depletion; assess phosphorylation if indicated |
| Weak or no signal | Limited recovery of nuclear HOXB9 or insufficient detectable protein | Check nuclear extraction and include a positive control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for HOXB9, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
Two the supplier anti-HOXB9 antibodies list human reactivity and show Western blot images: M05689 in MCF7 lysate and A05689-1 in K562, HEK293, and CACO-2 lysates. The supplied evidence is product WB data; no independent validation or publication evidence is provided.
Which to pick: For MCF7 lysate, consider M05689. For K562, HEK293, or CACO-2 lysates, A05689-1 provides documented WB conditions and an approximately 32 kDa band. Choose based on the closest tested sample and protocol.